Compare LQDT & SLBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LQDT | SLBT |
|---|---|---|
| Founded | 1999 | N/A |
| Country | United States | Taiwan |
| Employees | N/A | 20 |
| Industry | Catalog/Specialty Distribution | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 942.1M |
| IPO Year | 2005 | 2025 |
| Metric | LQDT | SLBT |
|---|---|---|
| Price | $43.02 | $1.56 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $40.00 | N/A |
| AVG Volume (30 Days) | ★ 181.8K | 79.0K |
| Earning Date | 05-07-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.10 | N/A |
| EPS | ★ 0.78 | N/A |
| Revenue | ★ $476,669,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $55.63 | ★ N/A |
| Revenue Growth | ★ 31.20 | N/A |
| 52 Week Low | $21.67 | $1.50 |
| 52 Week High | $44.09 | $6.25 |
| Indicator | LQDT | SLBT |
|---|---|---|
| Relative Strength Index (RSI) | 55.57 | 28.97 |
| Support Level | $36.82 | N/A |
| Resistance Level | $43.98 | $3.36 |
| Average True Range (ATR) | 0.99 | 0.21 |
| MACD | -0.00 | -0.04 |
| Stochastic Oscillator | 73.40 | 4.81 |
Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Retail Supply Chain Group (RSCG), and Machinio & Software Solutions. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.
SL Science Holding Ltd is a biomedical company specialized in developing cellular and gene therapies advancing regenerative medicine and cancer treatment. It utilizes immune stem cells to target cancer and bovine-derived milk exosomes to regenerate damaged tissues, thus potentially offering expansive medical applications for its products. With proprietary technologies such as Armed-T and Gamma Delta T cells, as well as exosome applications in skincare and cancer recovery. It operates in three segments namely Exosome products, CD-19 Armed-T products, and GDT cell therapy products. It derives revenue from Exosome products segment.